LA JOLLA PHARMACEUTICAL CO significant ownership

LA JOLLA PHARMACEUTICAL CO is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

LA JOLLA PHARMACEUTICAL CO significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage

Compare quarters

Export LA JOLLA PHARMACEUTICAL CO's holdings